The Maternal Vaccinations Act amends two parts of the Public Health Service Act to make pregnant and postpartum individuals explicit targets of federal vaccination awareness and grant activities and to modestly raise funding for those campaigns. It inserts pregnant and postpartum people into the language of the national immunization awareness program, adds obstetric providers to the list of outreach partners, and increases the program’s authorization from $15 million to $17 million for fiscal years 2027–2031.
Separately, the bill expands the scope of activities eligible under section 317(k)(1)(E) to include programs specifically designed to raise vaccination rates among pregnant and postpartum individuals — explicitly calling out racial and ethnic minority groups and their children as priorities. For compliance officers, program managers, and public-health contractors, the bill creates a clearer statutory hook for maternal-focused outreach while leaving implementation details to HHS and CDC rulemaking and grant guidance.
At a Glance
What It Does
The bill amends section 313 to add pregnant and postpartum individuals to the federal vaccination awareness campaign, adds obstetric providers to outreach channels, and raises authorized funding to $17 million per year for FY2027–2031. It also amends section 317(k)(1)(E) to authorize activities specifically aimed at increasing vaccination rates among pregnant and postpartum people, including racial and ethnic minorities and their children.
Who It Affects
Primary actors affected are HHS and CDC grant programs that administer immunization awareness and section 317 grants, state and local health departments that apply for or receive those funds, obstetric and prenatal care providers, and community organizations serving pregnant and postpartum populations. Vaccine program contractors and equity-focused public-health nonprofits will also see expanded eligibility for federal support.
Why It Matters
The change makes maternal vaccination an explicit statutory priority, which can shift grantmaking, messaging, and partnerships toward obstetric settings and postpartum outreach. That statutory language helps allocate federal awareness dollars and creates a direct grant-authority pathway to fund maternal-focused interventions and equity initiatives.
More articles like this one.
A weekly email with all the latest developments on this topic.
What This Bill Actually Does
The bill makes two targeted edits to existing federal immunization law to raise the visibility of maternal vaccination in national programs. First, it rewrites parts of the Public Health Service Act’s immunization-awareness provisions so that pregnant and postpartum individuals are named recipients of outreach, requires inclusion of obstetric providers among the listed clinical partners, and increases the program’s authorized annual funding to $17 million for a five-year block starting in FY2027.
Those edits are surgical: they do not create new federal programs, but they change which populations and provider types federal awareness campaigns must consider when HHS and CDC design outreach materials and grant solicitations.
Second, the bill amends the section of the Act that lists authorized activities for section 317 funds. It adds an explicit clause authorizing efforts to increase vaccination rates among pregnant and postpartum people and to address disparities affecting racial and ethnic minority groups and their children.
That language expands the statutory list of permissible activities, making maternal vaccination a clearly eligible objective for federal grants and cooperative agreements under section 317.Operationally, the effect will depend on how HHS and CDC translate the statutory edits into grant guidance and contracts. Agencies that already run national immunization campaigns can retool message content, revise distribution channels to emphasize obstetric settings, and prioritize maternal-focused outreach in Notices of Funding Opportunity.
State and local health departments, tribal organizations, and community-based groups will have a stronger statutory basis to request or design projects centered on pregnant and postpartum populations.The bill does not mandate clinical practices, change vaccine coverage rules, or identify particular vaccines. It changes who federal outreach and grant programs must consider and provides a modest, time-limited increase in authorized funding for those awareness activities; the practical reach of the law will depend on agency priorities, grant rules, and appropriation decisions in future fiscal years.
The Five Things You Need to Know
Section 313 of the Public Health Service Act is amended to expressly include pregnant and postpartum individuals as targets of the national vaccination awareness campaign.
The bill adds 'obstetric' to existing language so outreach must consider obstetric providers alongside prenatal and pediatric channels.
Congress authorizes $17,000,000 per year for the awareness program for fiscal years 2027 through 2031 (raising the previous authorization level).
Section 317(k)(1)(E) receives a new clause explicitly authorizing grant activities to increase vaccination rates of pregnant and postpartum individuals and their children.
The new section 317 language specifically mentions racial and ethnic minority groups, creating an explicit equity focus within the list of permissible grant activities.
Section-by-Section Breakdown
Every bill we cover gets an analysis of its key sections.
Short title
Provides the Act’s name, 'Maternal Vaccinations Act.' This is purely titular but makes the bill’s focus clear for agency communications and when HHS publishes implementing materials.
Include pregnant/postpartum populations and obstetric providers in awareness campaigns
Edits multiple subsections of section 313 to add pregnant and postpartum individuals as named recipients of the national immunization awareness efforts and adds 'obstetric' to the list of clinical outreach channels. Practically, that directs CDC and HHS when they design national messaging to include materials and distribution strategies tailored for maternity-care settings. The provision also revises the program’s authorization level and the fiscal window for funding, which changes the statutory ceiling for program spending but does not itself appropriate funds.
Authorized funding increased to $17M for FY2027–2031
Strikes the prior $15 million figure and replaces it with $17 million annually for fiscal years 2027–2031. This is an authorization of appropriations that raises the statutory maximum available to run awareness and outreach activities; appropriations committees still control actual funding. The specified FY window also creates a discrete period for planning and grant cycles tied to the increased authorization.
Makes maternal vaccination an explicit eligible activity under section 317 grants
Adds a new clause (vii) to the list of authorized activities under section 317(k)(1)(E) so that programs to increase vaccination rates of pregnant and postpartum individuals — including efforts focused on racial and ethnic minority groups and their children — are explicitly permissible uses of section 317 grant funding. That change broadens grant eligibility language and gives agencies and applicants a clearer legal basis to prioritize maternal-focused projects in grant solicitations and award criteria.
This bill is one of many.
Codify tracks hundreds of bills on Healthcare across all five countries.
Explore Healthcare in Codify Search →Who Benefits and Who Bears the Cost
Every bill creates winners and losers. Here's who stands to gain and who bears the cost.
Who Benefits
- Pregnant and postpartum individuals — gain targeted outreach and potentially more tailored education and access efforts backed by federal grants and campaign resources, which may reduce barriers to vaccination during pregnancy and after birth.
- Racial and ethnic minority communities and their children — the statute explicitly prioritizes these groups for maternal vaccination activities, increasing the likelihood that grant funds and campaign efforts will address disparities in uptake.
- Obstetric providers and clinics — the bill names obstetric settings as formal outreach partners, which can unlock funding and technical assistance for integrating vaccination counseling and on-site immunization into prenatal and postpartum care workflows.
- Public-health grant applicants and community-based organizations — the explicit grant-eligibility language gives maternal-health projects a clearer claim in competitive section 317 funding processes, potentially improving funding prospects for organizations serving pregnant and postpartum populations.
Who Bears the Cost
- HHS/CDC program offices — must draft new guidance, revise solicitations, and administer expanded or refocused grants; those administrative costs and re-prioritization efforts fall to agencies unless appropriations cover implementation.
- State and local health departments — while eligible for grants, departments must realign outreach strategies and may need to reassign staff or compete for limited funds to develop maternal-specific programs.
- Small community organizations and clinics — to access new grants, these entities may face administrative burdens (grant-writing, reporting, compliance) and may need to invest in capacity-building to meet federal grant requirements.
Key Issues
The Core Tension
The central tension is between prioritizing a specific, equity-focused population within a broad national immunization program and relying on limited, flexible grant dollars to achieve that priority: naming pregnant and postpartum people as a statutory priority can steer messaging and funding, but without substantial, sustained resources or prescriptive implementation rules, the change risks generating unmet demand and uneven results across jurisdictions.
The bill changes statutory priorities but leaves most implementation details to HHS and CDC. That creates both flexibility and uncertainty: agencies can tailor programs to local needs, but the absence of specified metrics, timelines, or required program components means outcomes will depend heavily on subsequent grant guidance and appropriation levels.
The $2 million per-year increase is modest relative to national immunization efforts, so agencies will need to decide whether to concentrate funds in a few large initiatives (e.g., national campaign materials for obstetric settings) or distribute smaller grants widely.
The legislation explicitly highlights racial and ethnic minority groups and children of vaccinated pregnant/postpartum individuals, which signals an equity intent but does not define the populations, measurement approaches, or accountability mechanisms needed to reduce disparities. Coordination across obstetric care providers, pediatric providers, state immunization programs, and community organizations is necessary but administratively complex; the bill does not create new coordination structures or funding for multi-stakeholder partnerships.
Finally, because the bill does not alter coverage, reimbursement, or clinical guidance for vaccines, outreach may raise demand without addressing structural access barriers like provider stocking, payment, or postpartum care gaps.
Try it yourself.
Ask a question in plain English, or pick a topic below. Results in seconds.